I Illumina Inc.
| Market Cap | $19.48B |
| P/E Ratio | 23.37 |
| Forward P/E | 21.83 |
| Dividend Yield | — |
| Beta | 1.49 |
| 52W Range | $70.30 - $153.95 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Triple Frond Partners Triple Frond Partners | 5.11% | $49.00K | 374,160 | Reduce 4.21% |
| Samantha McLemore Patient Capital Management | 2.91% | $75.52M | 575,768 | Reduce 0.96% |
Insider Trading
| Insider Name of the company insider who made the trade 7 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Davies Scott MChief Legal Officer | Sale | 1,336 | $116.18 | $155.22K | 20 Feb 2026 | 24 Feb 2026 |
| Leckman PatriciaSVP, Chief People Officer | Sale | 2,370 | $116.18 | $275.35K | 18 Feb 2026 | 18 Feb 2026 |
| Gottlieb Scott | Buy | 200 | $117.81 | $23.56K | 09 Feb 2026 | 11 Feb 2026 |
| Davies Scott MChief Legal Officer | Sale | 323 | $136.09 | $43.96K | 12 Dec 2025 | 16 Dec 2025 |
| Wedel Christensen JakobSVP, Strategy/Corp Development | Sale | 549 | $129.27 | $70.97K | 08 Dec 2025 | 09 Dec 2025 |
| Gottlieb Scott | Buy | 500 | $122.13 | $61.06K | 03 Nov 2025 | 05 Nov 2025 |
| Scott GottliebDirector | Buy | 500 | $122.13 | $61.06K | 03 Nov 2025 | 05 Nov 2025 |
Frequently Asked Questions
What is ILMN stock price today?
Illumina Inc. (ILMN) is currently trading at $127.38. The stock has a 52-week range of $70.30 to $153.95 and a market capitalization of $19.48B.
Is ILMN a good stock to buy in 2026?
Illumina Inc. has a P/E ratio of 23.4 (forward P/E: 21.8), a dividend yield of none, and 1-year performance of +66.7%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ILMN stock?
There have been 7 insider transactions for ILMN in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ILMN stock performed over the past year?
Illumina Inc. (ILMN) has returned +66.7% over the past 12 months. The stock traded between $70.30 and $153.95 during this period, and is currently at $127.38.
Which hedge funds own ILMN (Illumina Inc.)?
2 tracked hedge funds currently hold ILMN in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ILMN's market cap and valuation?
Illumina Inc. (ILMN) has a market capitalization of $19.48B. The trailing P/E ratio is 23.4 and forward P/E is 21.8. The stock is classified in the Healthcare sector.
What is ILMN's revenue and profitability?
Illumina Inc. reported revenue of $4.34B with net income of $850.00M and a profit margin of 0.20%. The stock has a beta of 1.49.
What sector is ILMN in and who are its biggest institutional holders?
Illumina Inc. (ILMN) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.